Every 10-Q that Accuray Incorporated (ARAY) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ARAY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARAY filings page.
Accuray Incorporated reported weaker results for the quarter ended March 31, 2026. Net revenue fell to $104.8 million from $113.2 million a year earlier, while the company posted a net loss of $11.8 million versus a $1.3 million loss.
For the first nine months of fiscal 2026, revenue declined to $301.0 million from $331.0 million, and net loss widened sharply to $47.3 million from $2.7 million. Results were pressured by higher interest expense of $24.2 million, supply chain and inflation headwinds, and $15.4 million of restructuring costs tied to an FY26 plan that reduced the global workforce by roughly 18% in two waves.
Accuray ended the period with $44.4 million in cash, cash equivalents and restricted cash and $179.5 million of total debt, including a high-cost Term Loan Facility with an effective rate of 24.5%. The company disclosed a Nasdaq notice for falling below the $1.00 minimum bid price, with a compliance period through August 3, 2026, and highlighted ongoing risks around macroeconomic conditions and compliance with leverage, fixed charge coverage and liquidity covenants, although it currently expects to fund operations for at least the next 12 months.
Accuray Incorporated reported weaker results for the quarter ended December 31, 2025. Total net revenue fell to $102.2 million from $116.2 million a year earlier, as product sales declined notably, partly offset by higher service revenue.
The company swung to a net loss of $13.8 million for the quarter, versus net income of $2.5 million in the prior-year period, as gross profit dropped and it recorded $6.1 million of restructuring charges. For the first six months, revenue was $196.2 million with a net loss of $35.4 million.
Accuray ended the period with $41.3 million in cash and cash equivalents and total assets of $448.0 million. Debt remains substantial, with $149.2 million outstanding under a high-cost term loan and $18.0 million of 3.75% convertible notes. Management cites inflation, supply chain pressures, and weaker radiotherapy capital spending as ongoing headwinds, but believes current cash, facilities, and expected cash flows will fund operations for at least the next 12 months, while noting uncertainty around future compliance with financial covenants.
Accuray Incorporated filed an amended quarterly report to restate its remaining performance obligations (RPO) disclosure and acknowledge internal control weaknesses. After re-evaluating its ASC 606 methodology, the company reduced total RPO as of September 30, 2025 to $59.3 million, down sharply from $866.0 million previously disclosed, mainly by excluding open system orders, upgrade orders, and customer credits that lacked substantive termination penalties.
The restatement does not change the previously reported balance sheet, income statement, equity, or cash flow figures, but prior RPO disclosure for the quarter can no longer be relied upon. Management and the audit committee concluded disclosure controls and procedures were not effective as of September 30, 2025 due to material weaknesses in review of footnote schedules and analysis of information for complete and accurate GAAP disclosures, and outlined remediation steps to strengthen these controls. For the quarter, Accuray reported net revenue of $93.9 million and a net loss of $21.7 million, with higher interest expense tied to its new term loan facilities.
Accuray (ARAY) filed its quarterly report showing a wider loss amid higher financing costs and softer product demand. Net revenue was $93.9 million, down from $101.5 million a year ago, as product sales fell while services grew. Gross profit declined to $26.5 million. Operating expenses were $37.9 million, and interest expense rose to $8.1 million, reflecting the new credit facilities and paid‑in‑kind interest. The company recorded a $1.9 million non‑cash loss from warrant remeasurement.
Accuray reported a net loss of $21.7 million (−$0.18 per share) versus a $4.0 million loss last year. Operating cash flow improved to $12.2 million, supported by accounts receivable collections, while inventories increased. Cash and cash equivalents were $63.3 million; total assets were $456.8 million and stockholders’ equity was $61.9 million. The company ended the quarter with $167.5 million of debt outstanding (net carrying value $140.2 million) and remained in compliance with debt covenants. Remaining performance obligations totaled $866.0 million. Management initiated a restructuring, eliminating about 3% of the workforce and recording $1.5 million in severance and $1.3 million in consulting costs.